期刊名称：EUROPEAN NEUROPSYCHOPHARMACOLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
European Neuropsychopharmacology provides a medium for the prompt publication of articles in the field of neuropsychopharmacology. Its scope encompasses clinical and basic research relevant to the effects of centrally acting agents in its broadest sense.
Types of Papers:
Full length Research Papers: detailing findings of original experimental or clinical research in any area of neuropsychopharmacology; Short Communications: brief research reports or results that have reached a stage where they are ready for preliminary communication; Reviews on specialised topics. Letters to the Editor relating to material published in the journal are also welcomed.
Audience
Neuropsychopharmacologists, psychiatrists, psychologists, behavioural pharmacologists.
Abstracting / Indexing
- BIOSIS
- CAS
- Current Contents/Life Sciences
- E-psyche
- EMBASE
- Elsevier BIOBASE
|
- Index Medicus
- Medline
- PsycINFO Psychological Abstracts
- PubMed
- Science Citation Index
|
Instructions to Authors
Submission of a paper to European Neuropsychopharmacology is understood to imply that the data contained therein has not previously been published (except in abstract form) nor is being considered for publication elsewhere, and that they have been tacitly or explicitly approved by the responsible authorities in the laboratory where the work was carried out. Manuscripts submitted under multiple authorship are reviewed under the assumption that all listed authors concur with the submission and have approved the final manuscript. If accepted, the paper shall not be published either whole or in part elsewhere in the same or any other language without the consent of the Publisher.
There are no submission or page charges.
Only submissions in English will be considered. One original plus three copies (copy sets of photographs must be original prints) should be submitted (for submission addresses, see inside front cover). NB: Copies of submitted manuscripts will not be returned except in the case of rejected articles, where only the original manuscript and figures are returned to the author. Papers that do not conform to the general criteria for publication in European Neuropsychopharmacology will be returned immediately to authors to avoid unnecessary delay in submission elsewhere. The decision of the Editors is final; the Editors cannot enter into correspondence about a paper that is considered unsuitable for publication.
Submissions Non-clinical manuscripts and related editorial correspondence should be addressed to: ENP Secretariat, PO Box 85410, 3508 AK Utrecht, The Netherlands. Clinical manuscripts and related editorial correspondence should be addressed to: Professor Stuart A. Montgomery, European Neuropsychopharmacology, PO Box 8751, London W13 8WH, UK.
Organisation of the manuscript Manuscripts should be typewritten/printed double-spaced with wide margins throughout; if a dot-matrix printer is used it must be of letter quality. Words to be printed in italics are to be underlined. Title page, abstract, tables, legends to figures and reference list should each be provided on separate sheets of paper.
The title page should include: the title, the name(s) and affiliation(s) of the author(s), and address for correspondence, and telephone/telefax numbers for editorial queries.
All articles should include an Abstract (a single paragraph of no more than 150 words), and 3-6 key words taken from Index Medicus for abstracting and indexing purposes.
The text should be ordered under the following headings: 1. Introduction, 2. Experimental procedures, 3. Results, 4. Discussion (may be combined with Results), Acknowledgements (when appropriate), References.
Short Communications should not be more than 1500 words or equivalent space including figures and tables. They should include an abstract of up to 75 words as well as key words and be concisely but adequately referenced.
Electronic manuscripts Electronic manuscripts have the advantage that there is no need for the rekeying of text, thereby avoiding the possibility of introducing errors and resulting in reliable and fast delivery of proofs. The preferred storage medium is a 5¼ or 3½ inch disk in MS-DOS format, although other systems are welcome, e.g., NEC and Macintosh (in this case, save your file in the usual manner, do not use the option, save in MS-DOS format). Please do not split the article into separate files (title page as one file, text as another, etc.). Ensure that the letter l and digit 1 (also letter O and digit 0) have been used properly, and structure your article (tabs, indents, etc.) consistently. Characters not available on your wordprocessor (Greek letters, mathematical symbols, etc.) should not be left open but indicated by a unique code (e.g., gralpha, @, #, etc., for the Greek letter ). Such codes should be used consistently throughout the entire text. Please make a list of such codes and provide a key. Do not allow your wordprocessor to introduce word splits and do not use a justified layout. Please adhere strictly to the general instructions on style/arrangement and, in particular, the reference style of the journal. It is very important that you save your file in the wordprocessor format. If your wordprocessor features the option to save files in flat ASCII, please do not use it. Format your disk correctly and ensure that only the relevant file (one complete article only) is on the disk. Also, specify the type of computer and wordprocessing package used and label the disk with your name and the name of the file on the disk. At final acceptance, your disk plus one, final, printed and exactly matching version (as a printout) should be submitted together to the accepting editor. It is important that the file on disk and the printout are identical. Both will then be forwarded by the editor to Elsevier. Further information may be obtained from the Publisher.
Illustrations Photographs should be presented as glossy prints with high contrast. Magnification should be indicated by a line representing the actual scale of reproduction (0.1 m, 1 m, or 10 m); the use of magnification factors is to be avoided where possible. Illustrations will not be redrawn by the Publisher: line figures should be suitable for direct reproduction. They should be prepared with black ink on white paper, or be black-and-white prints; they should be completely and consistently lettered, the size of the lettering being appropriate to that of the illustration, taking into account the necessary reduction in size. Complex chemical structures should be submitted as sharp, clear prints already reduced to the required width while retaining perfect legibility. Illustrations should be designed to fit either a single column (84 mm wide) or the full text width (175 mm). However, if specifically requested by the author(s), plates may be reproduced larger than the typeset area. all originals for these should have the same proportions to achieve uniformity in their presentation. NB: When plates are required to fill the entire page, the originals should have the dimensions 215 285 mm and contain no essential information or labelling near the edges. Each illustration should be clearly marked on the reverse side with the name of the author(s), the number of the illustration and its orientation (top); use a soft pencil or preferably, a felt-tipped pen for marking photographs.
Colour figures will be included subject to the authors' agreement to defray part of the cost of reproduction.
Tables All tables must be cited in the text, have titles, and be numbered consecutively with Arabic numerals. Table titles should be complete but brief. Information other than that defining the data should be presented as footnotes. Only horizontal rules should be included, and kept to a minimum.
References (Harvard system) Authors are responsible for the accuracy of the references. Only published articles and those in press (the journal should be stated) may be included; unpublished results and personal communications should be cited as such in the text. In the text a reference should be cited by author and date; where there are more than two authors, state first author's name followed by et al. References should be listed alphabetically at the end of the paper and include, in the following order: all authors (surnames followed by initials), year in parentheses, journal title (abbreviated according to the International List of Periodical Title Word Abbreviations), volume number and inclusive page numbers. For books, the editors' names, book title, publisher and publisher's location should appear before volume and page numbers. See the following examples of listing a journal article, monograph, and book chapter, respectively:
Examples:
Montgomery, S.A. and Green, M. (1988) Use of cholecystokinin in schizophrenia (Review). Psychol. Med. 18, 593-603.
Van Ree, J.M. and Matthysse, S. (1986) Psychiatric Disorders: Neurotransmitters and Neuropeptides. Elsevier, Amsterdam.
Herbert, J. and McGregor, A. (1990) Neuroendocrine and behavioural effects of POMC peptides. In: Van Ree, J.M., Mulder, A.H., Wiegant, V.M. and van Wimersma Greidanus, T.B. (Eds.), New Leads in Opioid Research. Excerpta Medica, Amsterdam, pp. 3-5.
Nomenclature Metric units must be used throughout; laboratory units must be followed by SI (Syst¨¨me International) units. The generic name of the drug should be used unless the specific trade name of the drug is directly relevant to the discussion. For receptor nomenclature, authors are referred to the special supplement of Trends in Pharmacological Sciences devoted to this.
Ethics of experimentation Procedures involving experiments on human subjects should be in accordance with the ethical standards of the Committee on Human Experimentation of the institution in which the experiments were done or in accordance with the Helsinki Declaration of 1975. Procedures involving experimentation on animals should be done in accordance with the guidelines of the institution in which the experiments were done.
Proofs One set of proofs will be supplied to the author to check for type-setting accuracy: no changes to the manuscript will be allowed at this stage. Elsevier will do everything possible to correct your article and publish it accurately and without delay. It is important, therefore, to ensure that all author corrections are marked clearly on your proofs and returned to us in one communication. No additional corrections are possible following receipt by Elsevier of the first set of marked up proofs. In the interests of publication time, authors should respond as quickly as possible, preferably by FAX
50 free reprints are supplied per contribution; additional reprints may be ordered at the prices quoted on the order form sent to the corresponding author.
Editorial Board
Editors-in-Chief:
J.M. van Ree, Rudolf Magnus Institute, Utrecht, The Netherlands
S.A. Montgomery, St. Mary's Hospital Medical School, London, UK
Editorial Board H. Akil, Ann Arbor, MI, USA
A.C. Altamura, Milan, Italy
F. Artigas, Barcelona, Spain
I. Bitter, Budapest, Hungary
P. Blier, Montreal, Canada
O. Civelli, Irvine, Ca. , USA
G. Goodwin, Oxford, UK
T. Higuchi, Kanagawa, Japan
R.S. Kahn, Utrecht, The Netherlands
J.M. Kane, Glen Oaks, NY, USA
S. Kasper, Vienna, Austria
C. Köhler, Sodertalje, Sweden
G. Koob, La Jolla, CA, USA
M.H. Lader, London, UK
Y. Lecrubier, Paris, France
P. Linkowski, Brussels, Belgium
D. Marazziti, Pisa, Italy
C.B. Nemeroff, Atlanta, GA, USA
S.O. Ogren, Stockholm, Sweden
A.J. Rush, Dallas, TX, USA
A.F. Schatzberg, Stanford, CA, USA
C.A. Tamminga, Baltimore MD, USA
J.W.G. Tiller, Melbourne, Australia
J.L. Waddington, Dublin, Ireland
S. Yamawaki, Hiroshima, Japan
J. Zohar, Tel Hashomer, Israel
E.E. Zvartau, St. Petersburg, Russia
|
